让“出远门”成为透析患者的日常——17个省份33家机构参与,打通跨区域就医难题

Core Viewpoint - The "Tongpu Shenzhou Wuyouxing" initiative, launched by a state-owned medical institution, aims to address the long-standing issue of cross-regional dialysis for patients, enabling them to travel and receive treatment seamlessly across different provinces [1][3][4]. Group 1: Background and Challenges - Nearly 90% of dialysis patients are confined within a 50-kilometer radius of their treatment centers, limiting their ability to travel for family visits or vacations [2]. - The challenges faced by dialysis patients include inconsistent treatment standards across regions, lack of information sharing between medical institutions, and barriers in medical insurance for cross-regional treatment [2][8]. Group 2: Implementation and Innovations - The initiative began with a professional meeting in November 2024, where a proposal was made to facilitate travel for dialysis patients, leading to the development of standardized documentation and processes for patient transfer [3][6]. - A comprehensive set of standardized documents was created within three weeks, covering all aspects from pre-travel assessments to emergency procedures, supported by a network of nearly 400 medical institutions across 28 provinces [3][6]. Group 3: Patient Experiences and Outcomes - As of December 15, 2024, the first patient, Aunt Jiang, successfully received dialysis treatment in Chengdu, demonstrating the effectiveness of the initiative in providing seamless care [4][5]. - By October 2025, the program had assisted 32 patients with 110 instances of cross-regional dialysis, achieving a 100% satisfaction rate among participants [5][6]. Group 4: Systemic Impact and Future Directions - The initiative represents a model for improving healthcare quality and accessibility, emphasizing the importance of life quality enhancement for patients beyond mere survival [7]. - The program's success highlights the potential for replicable pathways in addressing cross-regional medical collaboration challenges, with implications for broader healthcare reforms in China [7][8].